ISEC 40T

SGD 0.31 +0.00% +0.00 Updated 21 Oct 2026, 12:02 SGT

Financials

ISEC HEALTHCARE LTD. Annual Report 2025

Open annual report

Explore the statements

34 tables

Statements of financial position — FY2025 report

34 metrics

Units appear below each metric. Scroll to compare years

Statements of financial position — FY2025 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2025Group2024Group2025Company2024Company Source
Non-current assets
Property, plant and equipment$’000 47,29929,7935753 PDF p. 56
Right-of-use assets$’000 9,54710,8995691 PDF p. 56
Intangible assets$’000 54,58253,174217234 PDF p. 56
Investment in subsidiaries$’000 ––60,99760,997 PDF p. 56
Net investment in sublease$’000 –50–– PDF p. 56
Deferred tax assets$’000 4302751315 PDF p. 56
Total non-current assets$’000 111,85894,19161,34061,390 PDF p. 56
Current assets
Inventories$’000 2,7692,501–– PDF p. 56
Trade and other receivables$’000 6,6975,95016,73418,895 PDF p. 56
Prepayments$’000 5224363730 PDF p. 56
Net investment in sublease$’000 5057–– PDF p. 56
Current income tax asset$’000 215––– PDF p. 56
Cash and cash equivalents$’000 23,79415,9112,9971,200 PDF p. 56
Total current assets$’000 34,04724,85519,76820,125 PDF p. 56
Total assets$’000 145,905119,04681,10881,515 PDF p. 56
EQUITY
Share capital$’000 76,53276,38176,53276,381 PDF p. 56
Other reserves$’000 (7,766)(10,007)–156 PDF p. 56
Retained earnings$’000 33,02623,6854,1964,598 PDF p. 56
Equity attributable to owners
of the Company$’000 101,79290,05980,72881,135 PDF p. 56
Non-controlling interests$’000 1,7851,680–– PDF p. 56
Total equity$’000 103,57791,73980,72881,135 PDF p. 56
Non-current liabilities
Borrowings$’000 16,502767–– PDF p. 56
Lease liabilities$’000 8,1589,4452361 PDF p. 56
Deferred tax liabilities$’000 1305–– PDF p. 56
Provisions$’000 1763241514 PDF p. 56
Total non-current liabilities$’000 24,96610,5413875 PDF p. 56
Current liabilities
Trade and other payables$’000 13,80512,425294265 PDF p. 56
Borrowings$’000 260672–– PDF p. 56
Lease liabilities$’000 2,1372,2083836 PDF p. 56
Provisions$’000 173––– PDF p. 56
Current income tax payable$’000 9871,461104 PDF p. 56
Total current liabilities$’000 17,36216,766342305 PDF p. 56
Total liabilities$’000 42,32827,307380380 PDF p. 56
Total equity and liabilities$’000 145,905119,04681,10881,515 PDF p. 56
Definitions & sources

Consolidated statement of profit or loss and other comprehensive income — FY2025 report

20 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of profit or loss and other comprehensive income — FY2025 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2025Group2024Group Source
Consolidated statement of profit or loss and other comprehensive income — FY2025 report
Revenue$’000 79,21174,197 PDF p. 57
Cost of sales$’000 (45,850)(41,529) PDF p. 57
Gross profit$’000 33,36132,668 PDF p. 57
Other item of income Other income$’000 8541,209 PDF p. 57
Other items of expense Selling and distribution expenses$’000 (294)(246) PDF p. 57
Administrative expenses$’000 (15,445)(13,871) PDF p. 57
Other expenses$’000 (128)(1,971) PDF p. 57
Finance costs$’000 (641)(602) PDF p. 57
Profit before income tax$’000 17,70717,187 PDF p. 57
Income tax expense$’000 (4,290)(4,293) PDF p. 57
Profit for the year$’000 13,41712,894 PDF p. 57
Items that may be reclassified subsequently to profit or loss:
Foreign currency translation of subsidiaries$’000 2,3262,949 PDF p. 57
Other comprehensive income for the year, net of tax$’000 2,3262,949 PDF p. 57
Total comprehensive income for the year$’000 15,74315,843 PDF p. 57
Profit for the year attributable to: Owners of the Company$’000 13,36712,824 PDF p. 57
Non-controlling interests$’000 5070 PDF p. 57
Subtotal$’000 13,41712,894 PDF p. 57
Total comprehensive income attributable to:
Owners of the Company$’000 15,73715,694 PDF p. 57
Non-controlling interests$’000 6149 PDF p. 57
Subtotal$’000 15,74315,843 PDF p. 57
Definitions & sources

Earnings per share — FY2025 report

2 metrics

Units appear below each metric. Scroll to compare years

Earnings per share — FY2025 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2025Group2024Group Source
Total comprehensive income attributable to:
Earnings per share – basic (in cents)cents per share 2.322.23 PDF p. 57
– diluted (in cents)cents per share 2.322.23 PDF p. 57
Definitions & sources

Consolidated statement of changes in equity — FY2025 — physical58 — FY2025 report

11 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of changes in equity — FY2025 — physical58 — FY2025 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2025Group — Share capital2025Group — Foreign currency translation reserve2025Group — Merger reserve2025Group — Capital reserve2025Group — Share compensation/option reserve2025Group — Retained earnings2025Group — Equity attributable to owners of the Company2025Group — Non-controlling interests2025Group — Total equity Source
Consolidated statement of changes in equity — FY2025 — physical58 — FY2025 report
At 1 January 2025$’000 76,381(2,128)(3,572)(4,463)15623,68590,0591,68091,739 PDF p. 58
Profit for the year$’000 –––––13,36713,3675013,417 PDF p. 58
Other comprehensive income Foreign currency translation$’000 –2,370––––2,370(44)2,326 PDF p. 58
Total comprehensive income for the year$’000 –2,370–––13,36715,737615,743 PDF p. 58
Transactions with owners of the Company (1) Issuance of ordinary shares$’000 156–––(156)–––– PDF p. 58
Dividends$’000 –––––(4,026)(4,026)–(4,026) PDF p. 58
Share issue expenses$’000 (5)–––––(5)–(5) PDF p. 58
Total transactions with owners of the Company$’000 151–––(156)(4,026)(4,031)–(4,031) PDF p. 58
Transaction with non-controlling interests Subscription of shares in subsidiaries by (2) non-controlling interests$’000 –––27––2799126 PDF p. 58
Total transaction with non-controlling interests$’000 –––27––2799126 PDF p. 58
At 31 December 2025$’000 76,532242(3,572)(4,436)–33,026101,7921,785103,577 PDF p. 58
Definitions & sources

Consolidated statement of changes in equity — FY2024 — physical59 — FY2025 report

13 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of changes in equity — FY2024 — physical59 — FY2025 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2024Group — Share capital2024Group — Foreign currency translation reserve2024Group — Merger reserve2024Group — Capital reserve2024Group — Share compensation/option reserve2024Group — Retained earnings2024Group — Equity attributable to owners of the Company2024Group — Non-controlling interests2024Group — Total equity Source
Consolidated statement of changes in equity — FY2024 — physical59 — FY2025 report
At 1 January 2024$’000 76,138(4,998)(3,572)(4,463)12817,47680,7091,44182,150 PDF p. 59
Profit for the year$’000 –––––12,82412,8247012,894 PDF p. 59
Other comprehensive income Foreign currency translation$’000 –2,870––––2,870792,949 PDF p. 59
Total comprehensive income for the year$’000 –2,870–––12,82415,69414915,843 PDF p. 59
Transactions with owners of the Company (1) Issuance of ordinary shares$’000 209–––––209–209 PDF p. 59
Reclassification of fair value$’000 34–––(34)–––– PDF p. 59
Dividends$’000 –––––(6,615)(6,615)–(6,615) PDF p. 59
Share-based compensation (2) expense$’000 ––––67–67–67 PDF p. 59
(3) Reversal of share options$’000 ––––(5)–(5)–(5) PDF p. 59
Total transactions with owners of the Company$’000 243–––28(6,615)(6,344)–(6,344) PDF p. 59
Transaction with non-controlling interests Subscription of share in a subsidiary by (4) non-controlling interest$’000 –––––––9090 PDF p. 59
Total transaction with non-controlling interests$’000 –––––––9090 PDF p. 59
At 31 December 2024$’000 76,381(2,128)(3,572)(4,463)15623,68590,0591,68091,739 PDF p. 59
Definitions & sources

Company statement of changes in equity — FY2025 — FY2025 report

7 metrics

Units appear below each metric. Scroll to compare years

Company statement of changes in equity — FY2025 — FY2025 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2025Company — Share capital2025Company — Share compensation/option reserve2025Company — Retained earnings2025Company — Total equity Source
2025
At 1 January 2025$’000 76,3811564,59881,135 PDF p. 60
Profit for the year, representing total comprehensive income for the year$’000 ––3,6243,624 PDF p. 60
Transactions with owners of the Company Issuance of ordinary shares$’000 156(156)–– PDF p. 60
Dividends$’000 ––(4,026)(4,026) PDF p. 60
Share issue expenses$’000 (5)––(5) PDF p. 60
Total transactions with owners of the Company$’000 151(156)(4,026)(4,031) PDF p. 60
At 31 December 2025$’000 76,532–4,19680,728 PDF p. 60
Definitions & sources

Company statement of changes in equity — FY2024 — FY2025 report

9 metrics

Units appear below each metric. Scroll to compare years

Company statement of changes in equity — FY2024 — FY2025 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2024Company — Share capital2024Company — Share compensation/option reserve2024Company — Retained earnings2024Company — Total equity Source
2024
At 1 January 2024$’000 76,1381285,38981,655 PDF p. 60
Profit for the year, representing total comprehensive income for the year$’000 ––5,8245,824 PDF p. 60
Transactions with owners of the Company Issuance of ordinary shares$’000 209––209 PDF p. 60
Reclassification of fair value$’000 34(34)–– PDF p. 60
Dividends$’000 ––(6,615)(6,615) PDF p. 60
Share-based compensation expense$’000 –67–67 PDF p. 60
Reversal of share options$’000 –(5)–(5) PDF p. 60
Total transactions with owners of the Company$’000 24328(6,615)(6,344) PDF p. 60
At 31 December 2024$’000 76,3811564,59881,135 PDF p. 60
Definitions & sources

Consolidated statement of cash flows — physical61 — FY2025 report

27 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of cash flows — physical61 — FY2025 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2025Group2024Group Source
Cash flows from operating activities
Profit before income tax$’000 17,70717,187 PDF p. 61
Adjustments for:
Allowance for expected credit losses, net$’000 9635 PDF p. 61
Amortisation of intangible assets$’000 55404 PDF p. 61
Depreciation of property, plant and equipment$’000 2,4111,773 PDF p. 61
Depreciation of right-of-use assets$’000 2,4432,145 PDF p. 61
Interest income$’000 (356)(326) PDF p. 61
Interest expense$’000 641602 PDF p. 61
Impairment loss for goodwill$’000 –1,520 PDF p. 61
Gain on lease modification$’000 (16)– PDF p. 61
Loss on lease remeasurement$’000 27– PDF p. 61
Property, plant and equipment written-off$’000 *8 PDF p. 61
Share-based compensation expense$’000 –67 PDF p. 61
Rental rebate$’000 (2)– PDF p. 61
Reversal of share options$’000 –(5) PDF p. 61
Operating cash flows before movements in working capital$’000 23,00623,410 PDF p. 61
Working capital changes : – Inventories$’000 (205)(140) PDF p. 61
– Trade and other receivables$’000 (668)(615) PDF p. 61
– Prepayments$’000 (68)(85) PDF p. 61
– Trade and other payables$’000 1,929(477) PDF p. 61
Cash generated from operations$’000 23,99422,093 PDF p. 61
Income tax paid, net$’000 (5,020)(4,451) PDF p. 61
Net cash generated from operating activities$’000 18,97417,642 PDF p. 61
Cash flows from investing activities
Purchase of property, plant and equipment$’000 (19,548)(11,781) PDF p. 61
Purchase of intangible assets$’000 (66)(285) PDF p. 61
Interest received$’000 352319 PDF p. 61
(1) Payment to vendors$’000 –(1,033) PDF p. 61
Net cash used in investing activities$’000 (19,262)(12,780) PDF p. 61
Definitions & sources

* Less than $1,000.

Consolidated statement of cash flows — physical62 — FY2025 report

15 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of cash flows — physical62 — FY2025 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2025Group2024Group Source
Cash flows from financing activities
Advances from non-controlling interests$’000 –474 PDF p. 62
Dividends paid$’000 (4,026)(6,615) PDF p. 62
Subscription of shares in a subsidiary by non-controlling Interest$’000 12690 PDF p. 62
Share issue expenses$’000 (5)– PDF p. 62
Proceeds from exercise of share option s$’000 –209 PDF p. 62
Principal elements of lease payments, net$’000 (2,452)(1,916) PDF p. 62
Interest paid – lease liabilities$’000 (482)(471) PDF p. 62
Proceeds from bank loans$’000 15,47829 PDF p. 62
Repayment of loans$’000 (721)(855) PDF p. 62
Interest paid – loans$’000 (192)(74) PDF p. 62
Net cash generated from/(used in) financing activities$’000 7,726(9,129) PDF p. 62
Net increase/(decrease) in cash and cash equivalents$’000 7,438(4,267) PDF p. 62
Cash and cash equivalents at beginning of year$’000 15,91119,404 PDF p. 62
Effect of exchange rate changes on cash and cash equivalents$’000 445774 PDF p. 62
Cash and cash equivalents at end of year$’000 23,79415,911 PDF p. 62
Definitions & sources

Five-year revenue

1 metrics

Units appear below each metric. Scroll to compare years

Five-year revenue from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2021Group2022Group2023Group2024Group2025Group Source
Five-year financial review
REVENUESingapore dollars million 40.563.070.074.279.2 PDF p. 6
Definitions & sources

Original rounded chart values in S$millions; primary statement amounts in S$thousands remain separately represented.

Five-year profit attributable to shareholders

1 metrics

Units appear below each metric. Scroll to compare years

Five-year profit attributable to shareholders from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2021Group2022Group2023Group2024Group2025Group Source
Five-year financial review
PROFIT ATTRIBUTABLE TO SHAREHOLDERSSingapore dollars million 6.912.513.012.813.4 PDF p. 6
Definitions & sources

Original rounded chart values in S$millions; primary statement amounts in S$thousands remain separately represented.

Earnings per share calculation inputs

6 metrics

Units appear below each metric. Scroll to compare years

Earnings per share calculation inputs from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2025Group2024Group Source
Earnings per share
Profit for the year attributable to owners of the Company ($’000)$’000 13,36712,824 PDF p. 114
Weighted average number of ordinary shares in issue during the financial year applicable to basic earnings per shareordinary shares 575,514,237575,012,285 PDF p. 114
Effect of dilution
– Share options and performance share awardsordinary shares 186,315561,077 PDF p. 114
Earnings per share
Weighted average number of ordinary shares outstanding for diluted earnings per share computationordinary shares 575,700,552575,573,362 PDF p. 114
– basiccents per share 2.322.23 PDF p. 114
– dilutedcents per share 2.322.23 PDF p. 114
Definitions & sources

The EPS calculation is stated for the years ended 31 December. The report defines basic and diluted EPS on physical page 114; see the Earnings per share table notes.

Dividends on ordinary shares

5 metrics

Units appear below each metric. Scroll to compare years

Dividends on ordinary shares from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2025Group and Company2024Group and Company Source
Dividends on ordinary shares
– Final tax-exempt dividend for 2024: 0.70 cents (2023: 0.85 cents) per share$’000 4,0264,889 PDF p. 114
– First interim tax-exempt dividend for 2025: nil (2024: 0.30 cents) per share$’000 –1,726 PDF p. 114
Total dividends on ordinary shares$’000 4,0266,615 PDF p. 114
Proposed but not recognised as a liability as at 31 December
– Final tax-exempt dividends on ordinary shares for 2025 of 0.58 cents (2024: 0.70 cents) per share, subject to shareholders’ approval at the Annual General Meeting$’000 3,3394,026 PDF p. 114
Total proposed dividends$’000 3,3394,026 PDF p. 114
Definitions & sources

Paid final/interim cash dividends are distinct from proposed final amounts, which are subject to shareholder approval and not recognised as a liability at31December2025.

Gearing ratio

1 metrics

Units appear below each metric. Scroll to compare years

Gearing ratio from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2025Group2024Group Source
Capital management
Gearing ratio (%)percent 162 PDF p. 124
Definitions & sources

The Group defines its consolidated gearing ratio as total debt over total equity. Total debt relates to borrowings; total equity includes share capital, treasury shares (if any), other reserves, retained earnings and non-controlling interests. (Physical page 124.)

Dividend rates — paid and proposed

3 metrics

Units appear below each metric. Scroll to compare years

Dividend rates — paid and proposed from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2025Group and Company — preceding-year final paid/current interim/current proposed final2024Group and Company — preceding-year final paid/current interim/current proposed final Source
Paid final dividend
Final dividend for preceding financial yearSingapore cents per share 0.700.85 PDF p. 114
Paid interim dividend
First interim dividend for current financial yearSingapore cents per share nil0.30 PDF p. 114
Proposed; not recognised as liability; subject to approval
Proposed final dividend for current financial yearSingapore cents per share 0.580.70 PDF p. 114
Definitions & sources

Company statement of changes in equity — FY2023 — FY2024 report comparative

9 metrics

Units appear below each metric. Scroll to compare years

Company statement of changes in equity — FY2023 — FY2024 report comparative from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2023Company — Share capital2023Company — Treasury share reserve2023Company — Share compensation reserve2023Company — Retained earnings2023Company — Total equity Source
2023
At 1 January 2023$’000 75,484(105)1426,62182,142 PDF p. 65
Profit for the year, representing total comprehensive income for the year$’000 –––9,3099,309 PDF p. 65
Transactions with owners of the Company Issuance of ordinary shares$’000 539–––539 PDF p. 65
Transfer and use of treasury shares$’000 7105––112 PDF p. 65
Reclassification of fair value$’000 108–(108)–– PDF p. 65
Dividends$’000 –––(10,541)(10,541) PDF p. 65
Share-based compensation expense$’000 ––94–94 PDF p. 65
Total transactions with owners of the Company$’000 654105(14)(10,541)(9,796) PDF p. 65
At 31 December 2023$’000 76,138–1285,38981,655 PDF p. 65
Definitions & sources

The FY2024 report comparative prints a dash in retained earnings for transfer and use of treasury shares. The original FY2023 report printed112; both complete original table versions are retained.

Statements of financial position — FY2023 report

37 metrics

Units appear below each metric. Scroll to compare years

Statements of financial position — FY2023 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2023Group2022Group2023Company2022Company Source
Non-current assets
Property, plant and equipment$’000 16,99816,3167086 PDF p. 58
Right-of-use assets$’000 9,84310,877127162 PDF p. 58
Intangible assets$’000 52,87055,289–– PDF p. 58
Investment in subsidiaries$’000 ––62,48762,487 PDF p. 58
Investment in associate$’000 –––– PDF p. 58
Net investment in sublease$’000 107––– PDF p. 58
Deferred tax assets$’000 268196117 PDF p. 58
Total non-current assets$’000 80,08682,67862,69562,742 PDF p. 58
Current assets
Inventories$’000 2,2351,874–– PDF p. 58
Trade and other receivables$’000 4,9914,74917,38614,807 PDF p. 58
Prepayments$’000 3342932728 PDF p. 58
Net investment in sublease$’000 5450–– PDF p. 58
Current income tax asset$’000 318–– PDF p. 58
Cash and cash equivalents$’000 19,40420,6331,9585,045 PDF p. 58
Total current assets$’000 27,02127,61719,37119,880 PDF p. 58
Total assets$’000 107,107110,29582,06682,622 PDF p. 58
EQUITY
Share capital$’000 76,13875,48476,13875,484 PDF p. 58
Treasury share reserve$’000 –(105)–(105) PDF p. 58
Other reserves$’000 (12,905)(10,561)128142 PDF p. 58
Retained earnings$’000 17,47615,0545,3896,621 PDF p. 58
Equity attributable to owners of
the Company$’000 80,70979,87281,65582,142 PDF p. 58
Non-controlling interests$’000 1,4411,470–– PDF p. 58
Total equity$’000 82,15081,34281,65582,142 PDF p. 58
Non-current liabilities
Other payables$’000 –1,040–– PDF p. 58
Borrowings$’000 1,3271,767–– PDF p. 58
Lease liabilities$’000 8,7769,57397131 PDF p. 58
Deferred tax liabilities$’000 150299–– PDF p. 58
Provisions$’000 2351781413 PDF p. 58
Total non-current liabilities$’000 10,48812,857111144 PDF p. 58
Current liabilities
Trade and other payables$’000 10,59211,779256295 PDF p. 58
Borrowings$’000 843826–– PDF p. 58
Lease liabilities$’000 1,6141,6523433 PDF p. 58
Current income tax payable$’000 1,4201,829108 PDF p. 58
Provisions$’000 –10–– PDF p. 58
Total current liabilities$’000 14,46916,096300336 PDF p. 58
Total liabilities$’000 24,95728,953411480 PDF p. 58
Total equity and liabilities$’000 107,107110,29582,06682,622 PDF p. 58
Definitions & sources

Consolidated statement of profit or loss and other comprehensive income — FY2023 report

21 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of profit or loss and other comprehensive income — FY2023 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2023Group2022Group Source
Consolidated statement of profit or loss and other comprehensive income — FY2023 report
Revenue$’000 69,99462,954 PDF p. 59
Cost of sales$’000 (38,958)(34,187) PDF p. 59
Gross profit$’000 31,03628,767 PDF p. 59
Other item of income Other income$’000 471450 PDF p. 59
Other items of expense Selling and distribution expenses$’000 (129)(119) PDF p. 59
Administrative expenses$’000 (12,130)(10,312) PDF p. 59
Other expenses$’000 (1,283)(1,452) PDF p. 59
Finance costs$’000 (651)(555) PDF p. 59
Share of results of associate$’000 –(1) PDF p. 59
Profit before income tax$’000 17,31416,778 PDF p. 59
Income tax expense$’000 (4,164)(4,050) PDF p. 59
Profit for the year$’000 13,15012,728 PDF p. 59
Items that may be reclassified subsequently to profit or loss:
Foreign currency translation of subsidiaries$’000 (2,556)(2,433) PDF p. 59
Other comprehensive income for the year, net of tax$’000 (2,556)(2,433) PDF p. 59
Total comprehensive income for the year$’000 10,59410,295 PDF p. 59
Profit for the year attributable to: Owners of the Company$’000 12,96312,520 PDF p. 59
Non-controlling interests$’000 187208 PDF p. 59
Subtotal$’000 13,15012,728 PDF p. 59
Total comprehensive income attributable to:
Owners of the Company$’000 10,63310,097 PDF p. 59
Non-controlling interests$’000 (39)198 PDF p. 59
Subtotal$’000 10,59410,295 PDF p. 59
Definitions & sources

Earnings per share — FY2023 report

2 metrics

Units appear below each metric. Scroll to compare years

Earnings per share — FY2023 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2023Group2022Group Source
Total comprehensive income attributable to:
Earnings per share – basic (in cents)cents per share 2.262.22 PDF p. 59
– diluted (in cents)cents per share 2.262.22 PDF p. 59
Definitions & sources

Consolidated statement of changes in equity — FY2023 — physical60 — FY2023 report

13 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of changes in equity — FY2023 — physical60 — FY2023 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2023Group — Share capital2023Group — Treasury share reserve2023Group — Foreign currency translation reserve2023Group — Merger reserve2023Group — Capital reserve2023Group — Share compensation/option reserve2023Group — Retained earnings2023Group — Equity attributable to owners of the Company2023Group — Non-controlling interests2023Group — Total equity Source
Group
At 1 January 2023$’000 75,484(105)(2,668)(3,572)(4,463)14215,05479,8721,47081,342 PDF p. 60
Profit for the year$’000 ––––––12,96312,96318713,150 PDF p. 60
Other comprehensive income Foreign currency translation$’000 ––(2,330)––––(2,330)(226)(2,556) PDF p. 60
Total comprehensive income for the year$’000 ––(2,330)–––12,96310,633(39)10,594 PDF p. 60
Transactions with owners of the Company Issuance of ordinary (1) shares$’000 539––––––539–539 PDF p. 60
Transfer and use of (2) treasury shares$’000 7105–––––112–112 PDF p. 60
Reclassification of fair value$’000 108––––(108)–––– PDF p. 60
Dividends$’000 ––––––(10,541)(10,541)–(10,541) PDF p. 60
Share-based compensation (3) expense$’000 –––––94–94–94 PDF p. 60
Total transactions with owners of the Company$’000 654105–––(14)(10,541)(9,796)–(9,796) PDF p. 60
Transaction with non-controlling interests Subscription of share in a subsidiary by non-controlling (4) interest$’000 ––––––––1010 PDF p. 60
Total transaction with non-controlling interests$’000 ––––––––1010 PDF p. 60
At 31 December 2023$’000 76,138–(4,998)(3,572)(4,463)12817,47680,7091,44182,150 PDF p. 60
Definitions & sources

Original table footnotes on physical PDF page61: (1) During the financial year ended 31 December 2023, the Company issued and allotted 1,857,306 ordinary shares in the share capital of the Company (the “New Shares”), at an issue price of $0.29 per New Share, pursuant to the exercise of options granted under the ISEC Healthcare Share Option Scheme. Following the issue and allotment of the New Shares and the transfer and use of 386,400 treasury shares, the number of issued and paid-up shares in the share capital of the Company has increased from 572,230,206 ordinary shares (excluding 386,400 treasury shares) to 574,473,912 ordinary shares. (2) On 22 June 2023, the Company transferred and used 386,400 treasury shares for the allotment of shares pursuant to exercise of share options under the ISEC Healthcare Share Option Scheme. (3) The Company has granted 3,809,150 options under the ISEC Healthcare Share Option Scheme on 22 April 2020 and 680,000 share awards under the ISEC Healthcare Performance Share on 23 September 2022. (4) During the financial year ended 31 December 2023, the Company, through its wholly-owned subsidiary, ISEC Sdn. Bhd. (“ISEC KL”), incorporated ISEC (Klang) Sdn. Bhd. (“ISEC Klang”) and 65% of the total shareholding is held by ISEC KL. The initial issued and paid-up share capital of ISEC Klang was $29 (equivalent to RM100). In December 2023, ISEC Klang has increased its share capital from $29 (equivalent to RM100) to $29,000 (equivalent to RM100,000), through issuance of shares allotted to the existing shareholders of ISEC Klang in equal proportion to their existing shareholdings. ANNUAL REPORT 2023 ISEC HEALTHCARE LTD. 59 STATEMENTS OF CHANGES IN EQUITY

Consolidated statement of changes in equity — FY2022 — physical62 — FY2023 report

14 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of changes in equity — FY2022 — physical62 — FY2023 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2022Group — Share capital2022Group — Treasury share reserve2022Group — Foreign currency translation reserve2022Group — Merger reserve2022Group — Capital reserve2022Group — Share compensation/option reserve2022Group — Retained earnings2022Group — Equity attributable to owners of the Company2022Group — Non-controlling interests2022Group — Total equity Source
Group
At 1 January 2022$’000 70,068(105)(245)(3,572)(4,463)1396,93268,75455369,307 PDF p. 62
Profit for the year$’000 ––––––12,52012,52020812,728 PDF p. 62
Other comprehensive income Foreign currency translation$’000 ––(2,423)––––(2,423)(10)(2,433) PDF p. 62
Total comprehensive income for the year$’000 ––(2,423)–––12,52010,09719810,295 PDF p. 62
Transactions with owners of the Company Issuance of ordinary (1) shares$’000 5,432––––––5,432–5,432 PDF p. 62
Share issue expenses$’000 (16)––––––(16)–(16) PDF p. 62
Dividends$’000 ––––––(4,398)(4,398)–(4,398) PDF p. 62
Share-based compensation (2) expense$’000 –––––31–31–31 PDF p. 62
Forfeiture of share (3) options$’000 –––––(28)–(28)–(28) PDF p. 62
Total transactions with owners of the Company$’000 5,416––––3(4,398)1,021–1,021 PDF p. 62
Transactions with non-controlling interests Subscription of share in a subsidiary by non-controlling (4) interest$’000 ––––––––293293 PDF p. 62
Arising from (5) acquisition$’000 ––––––––426426 PDF p. 62
Total transactions with non-controlling interests$’000 ––––––––719719 PDF p. 62
At 31 December 2022$’000 75,484(105)(2,668)(3,572)(4,463)14215,05479,8721,47081,342 PDF p. 62
Definitions & sources

Original table footnotes on physical PDF page63: (1) On 26 May 2022, the Company, through its wholly-owned subsidiary, ISEC Sdn. Bhd. (“ISEC KL”), completed the acquisition of IE Centre Sdn. Bhd. (“IE Centre”) and Kampar Eye Sdn. Bhd. (“Kampar Eye”), by way of the allotment and issuance of 21,881,135 consideration shares, equivalent to fair value consideration of $5,432,000 to the vendors. (2) The Company has granted 3,809,150 options under the ISEC Healthcare Share Option Scheme on 22 April 2020. (3) The forfeiture of share options refers to participants who left the Group and hence no longer eligible for the options as at 31 December 2022. (4) In the prior financial year, ISEC (Kuching) Sdn. Bhd. (“ISEC Kuching”), a 51% owned indirect subsidiary of the Company through its wholly-owned subsidiary, ISEC KL, increased its share capital from $3,000 (equivalent to RM10,000) to $602,000 (equivalent to RM2,000,000), through issuance of shares allotted to the existing shareholders of the subsidiary in equal proportion to their existing shareholdings. (5) On 26 May 2022, the Company, through its wholly-owned subsidiary, ISEC KL, completed the acquisition of 50% plus 1 ordinary share each of ME Centre Sdn. Bhd. (“ME Centre”), TE Centre Sdn. Bhd. (“TE Centre”) and Taiping Eye Sdn. Bhd. (“Taiping Eye”) respectively, by way of subscription of 500,001 new ordinary shares in each of the respective entities at an offer price of approximately $0.315 (RM1.00) per share, with total net identifiable assets at fair value of $853,000 (equivalent to RM2,705,000). ANNUAL REPORT 2023 ISEC HEALTHCARE LTD. 61 STATEMENTS OF CHANGES IN EQUITY

Company statement of changes in equity — FY2023 — FY2023 report

9 metrics

Units appear below each metric. Scroll to compare years

Company statement of changes in equity — FY2023 — FY2023 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2023Company — Share capital2023Company — Treasury share reserve2023Company — Share compensation/option reserve2023Company — Retained earnings2023Company — Total equity Source
2023
At 1 January 2023$’000 75,484(105)1426,62182,142 PDF p. 64
Profit for the year, representing total comprehensive income for the year$’000 –––9,3099,309 PDF p. 64
Transactions with owners of the Company Issuance of ordinary shares$’000 539–––539 PDF p. 64
Transfer and use of treasury shares$’000 7105–112112 PDF p. 64
Reclassification of fair value$’000 108–(108)–– PDF p. 64
Dividends$’000 –––(10,541)(10,541) PDF p. 64
Share-based compensation expense$’000 ––94–94 PDF p. 64
Total transactions with owners of the Company$’000 654105(14)(10,541)(9,796) PDF p. 64
At 31 December 2023$’000 76,138–1285,38981,655 PDF p. 64
Definitions & sources

Original FY2023 treasury-share transfer has retained earnings112, component sum224 and total112. The separately retained FY2024 comparative prints a dash in that cell. Both original versions are preserved; this is a verified original-source discrepancy.

Company statement of changes in equity — FY2022 — FY2023 report

9 metrics

Units appear below each metric. Scroll to compare years

Company statement of changes in equity — FY2022 — FY2023 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2022Company — Share capital2022Company — Treasury share reserve2022Company — Share compensation/option reserve2022Company — Retained earnings2022Company — Total equity Source
2022
At 1 January 2022$’000 70,068(105)1392,47472,576 PDF p. 64
Profit for the year, representing total comprehensive income for the year$’000 –––8,5458,545 PDF p. 64
Transactions with owners of the Company Issuance of ordinary shares$’000 5,432–––5,432 PDF p. 64
Share issue expenses$’000 (16)–––(16) PDF p. 64
Dividends$’000 –––(4,398)(4,398) PDF p. 64
Share-based compensation expense$’000 ––31–31 PDF p. 64
Forfeiture of share options$’000 ––(28)–(28) PDF p. 64
Total transactions with owners of the Company$’000 5,416–3(4,398)1,021 PDF p. 64
At 31 December 2022$’000 75,484(105)1426,62182,142 PDF p. 64
Definitions & sources

Consolidated statement of cash flows — physical65 — FY2023 report

32 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of cash flows — physical65 — FY2023 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2023Group2022Group Source
Cash flows from operating activities
Profit before income tax$’000 17,31416,778 PDF p. 65
Adjustments for:
Allowance for expected credit losses, net$’000 2228 PDF p. 65
Amortisation of intangible assets$’000 534539 PDF p. 65
Depreciation of property, plant and equipment$’000 1,4651,168 PDF p. 65
Depreciation of right-of-use assets$’000 1,8901,748 PDF p. 65
Interest income$’000 (296)(226) PDF p. 65
Interest expense$’000 651555 PDF p. 65
Gain on lease modification$’000 (10)(8) PDF p. 65
Gain on disposal of property, plant and equipment$’000 –(2) PDF p. 65
Other income from rental rebates$’000 –(3) PDF p. 65
Property, plant and equipment written-off$’000 724 PDF p. 65
Write-back of provision for restoration costs$’000 (9)(21) PDF p. 65
Bad debts written off$’000 –33 PDF p. 65
Loss on disposal of associate$’000 –155 PDF p. 65
Share of results of associate$’000 –1 PDF p. 65
Share-based compensation expense$’000 9431 PDF p. 65
Forfeiture of share options$’000 –(28) PDF p. 65
Operating cash flows before movements in working capital$’000 21,66220,772 PDF p. 65
Working capital changes: – Inventories$’000 (467)(496) PDF p. 65
– Trade and other receivables$’000 103542 PDF p. 65
– Prepayments$’000 (44)(31) PDF p. 65
– Trade and other payables$’000 648521 PDF p. 65
Cash generated from operations$’000 21,90221,308 PDF p. 65
Income tax paid, net$’000 (4,731)(3,460) PDF p. 65
Net cash generated from operating activities$’000 17,17117,848 PDF p. 65
Cash flows from investing activities
Proceeds from disposal of property, plant and equipment$’000 –3 PDF p. 65
Purchase of property, plant and equipment$’000 (3,418)(5,713) PDF p. 65
Purchase of intangible assets$’000 (98)(2) PDF p. 65
Interest received$’000 292223 PDF p. 65
(1)(2) Payment to vendors$’000 (3,208)(577) PDF p. 65
Acquisition of subsidiaries, net of cash acquired$’000 –(5,534) PDF p. 65
Net cash used in investing activities$’000 (6,432)(11,600) PDF p. 65
Definitions & sources

Consolidated statement of cash flows — physical66 — FY2023 report

15 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of cash flows — physical66 — FY2023 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2023Group2022Group Source
Cash flows from financing activities
Advances from non-controlling interests$’000 1,182– PDF p. 66
Dividends paid$’000 (10,541)(4,398) PDF p. 66
Subscription of shares in a subsidiary by non-controlling interest$’000 10293 PDF p. 66
Share issue expenses$’000 –(16) PDF p. 66
Proceeds from exercise of share options 13,$’000 651– PDF p. 66
Principal elements of lease payments, net$’000 (1,768)(1,770) PDF p. 66
Interest paid – lease liabilities$’000 (453)(363) PDF p. 66
Proceeds from bank loan$’000 507– PDF p. 66
Repayment of loan$’000 (797)(844) PDF p. 66
Interest paid – loan$’000 (96)(69) PDF p. 66
Net cash used in financing activities$’000 (11,305)(7,167) PDF p. 66
Net decrease in cash and cash equivalents$’000 (566)(919) PDF p. 66
Cash and cash equivalents at beginning of year$’000 20,63322,494 PDF p. 66
Effect of exchange rate changes on cash and cash equivalents$’000 (663)(942) PDF p. 66
Cash and cash equivalents at end of year$’000 19,40420,633 PDF p. 66
Definitions & sources

Statements of financial position — FY2021 report

37 metrics

Units appear below each metric. Scroll to compare years

Statements of financial position — FY2021 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2021Group2020Group2021Company2020Company Source
Non-current assets
Property, plant and equipment$’000 9,42810,141913 PDF p. 53
Right-of-use assets$’000 6,3824,75450126 PDF p. 53
Intangible assets$’000 43,48444,423–– PDF p. 53
Investment in subsidiaries$’000 ––56,85556,855 PDF p. 53
Investment in associate$’000 156168–– PDF p. 53
Net investment in sublease$’000 50109–– PDF p. 53
Deposits$’000 207––– PDF p. 53
Deferred tax assets$’000 1405177 PDF p. 53
Subtotal$’000 59,84759,64656,92157,001 PDF p. 53
Current assets
Inventories$’000 1,2711,333–– PDF p. 53
Trade and other receivables$’000 3,7453,07414,16912,504 PDF p. 53
Prepayments$’000 2712472812 PDF p. 53
Net investment in sublease$’000 5856–– PDF p. 53
Cash and cash equivalents$’000 22,49424,1241,8676,109 PDF p. 53
Subtotal$’000 27,83928,83416,06418,625 PDF p. 53
Total assets$’000 87,68688,48072,98575,626 PDF p. 53
EQUITY
Share capital$’000 70,06870,05470,06870,054 PDF p. 53
Treasury share reserve$’000 (105)(105)(105)(105) PDF p. 53
Other reserves$’000 (8,141)(7,397)13971 PDF p. 53
Retained earnings$’000 6,9328,5572,4745,033 PDF p. 53
Equity attributable to owners of
the Company$’000 68,75471,10972,57675,053 PDF p. 53
Non-controlling interests$’000 553580–– PDF p. 53
Total equity$’000 69,30771,68972,57675,053 PDF p. 53
Non-current liabilities
Other payables$’000 –558–– PDF p. 53
Borrowing$’000 2,2443,141–– PDF p. 53
Lease liabilities$’000 5,2123,610–55 PDF p. 53
Deferred tax liabilities$’000 273378–– PDF p. 53
Provisions$’000 1531632121 PDF p. 53
Subtotal$’000 7,8827,8502176 PDF p. 53
Current liabilities
Trade and other payables$’000 7,0425,583306399 PDF p. 53
Borrowing$’000 849866–– PDF p. 53
Lease liabilities$’000 1,5601,6465573 PDF p. 53
Current income tax payable$’000 1,0368462725 PDF p. 53
Provisions$’000 10––– PDF p. 53
Subtotal$’000 10,4978,941388497 PDF p. 53
Total liabilities$’000 18,37916,791409573 PDF p. 53
Total equity and liabilities$’000 87,68688,48072,98575,626 PDF p. 53
Definitions & sources

Consolidated statement of profit or loss and other comprehensive income — FY2021 report

21 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of profit or loss and other comprehensive income — FY2021 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2021Group2020Group Source
Consolidated statement of profit or loss and other comprehensive income — FY2021 report
Revenue$’000 40,46936,327 PDF p. 54
Cost of sales$’000 (22,591)(20,270) PDF p. 54
Gross profit$’000 17,87816,057 PDF p. 54
Other item of income Other income$’000 9931,325 PDF p. 54
Other items of expense Selling and distribution expenses$’000 (57)(41) PDF p. 54
Administrative expenses$’000 (8,613)(8,345) PDF p. 54
Other expenses$’000 (703)(2,048) PDF p. 54
Finance costs$’000 (400)(424) PDF p. 54
Share of results of associate$’000 (12)(18) PDF p. 54
Profit before income tax$’000 9,0866,506 PDF p. 54
Income tax expense$’000 (2,207)(2,055) PDF p. 54
Profit for the year$’000 6,8794,451 PDF p. 54
Items that may be reclassified subsequently to profit or loss
Foreign currency translation of subsidiaries$’000 (813)72 PDF p. 54
Other comprehensive income for the year, net of tax$’000 (813)72 PDF p. 54
Total comprehensive income for the year$’000 6,0664,523 PDF p. 54
Profit for the year attributable to: Owners of the Company$’000 6,9054,690 PDF p. 54
Non-controlling interests$’000 (26)(239) PDF p. 54
Subtotal$’000 6,8794,451 PDF p. 54
Total comprehensive income attributable to:
Owners of the Company$’000 6,0934,762 PDF p. 54
Non-controlling interests$’000 (27)(239) PDF p. 54
Subtotal$’000 6,0664,523 PDF p. 54
Definitions & sources

Earnings per share — FY2021 report

2 metrics

Units appear below each metric. Scroll to compare years

Earnings per share — FY2021 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2021Group2020Group Source
Total comprehensive income attributable to:
Earnings per share – basic (in cents)cents per share 1.250.86 PDF p. 54
– diluted (in cents)cents per share 1.250.86 PDF p. 54
Definitions & sources

Consolidated statement of changes in equity — FY2021 — physical55 — FY2021 report

9 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of changes in equity — FY2021 — physical55 — FY2021 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2021Group — Share capital2021Group — Treasury share reserve2021Group — Foreign currency translation reserve2021Group — Merger reserve2021Group — Capital reserve2021Group — Share compensation/option reserve2021Group — Retained earnings2021Group — Equity attributable to owners of the Company2021Group — Non-controlling interests2021Group — Total equity Source
Group
At 1 January 2021$’000 70,054(105)567(3,572)(4,463)718,55771,10958071,689 PDF p. 55
Profit for the year$’000 ––––––6,9056,905(26)6,879 PDF p. 55
Other comprehensive income Foreign currency translation$’000 ––(812)––––(812)(1)(813) PDF p. 55
Total comprehensive income for the year$’000 ––(812)–––6,9056,093(27)6,066 PDF p. 55
Transactions with owners of the Company Issuance of ordinary (1) shares$’000 14––––––14–14 PDF p. 55
Dividends$’000 ––––––(8,530)(8,530)–(8,530) PDF p. 55
Share-based compensation expense$’000 –––––68–68–68 PDF p. 55
Total transactions with owners of the Company$’000 14––––68(8,530)(8,448)–(8,448) PDF p. 55
At 31 December 2021$’000 70,068(105)(245)(3,572)(4,463)1396,93268,75455369,307 PDF p. 55
Definitions & sources

Consolidated statement of changes in equity — FY2020 — physical56 — FY2021 report

9 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of changes in equity — FY2020 — physical56 — FY2021 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2020Group — Share capital2020Group — Treasury share reserve2020Group — Foreign currency translation reserve2020Group — Merger reserve2020Group — Capital reserve2020Group — Share compensation/option reserve2020Group — Retained earnings2020Group — Equity attributable to owners of the Company2020Group — Non-controlling interests2020Group — Total equity Source
Group
At 1 January 2020$’000 64,741(105)495(3,572)(4,463)–6,52963,62547864,103 PDF p. 56
Profit for the year$’000 ––––––4,6904,690(239)4,451 PDF p. 56
Other comprehensive income Foreign currency translation$’000 ––72––––72–72 PDF p. 56
Total comprehensive income for the year$’000 ––72–––4,6904,762(239)4,523 PDF p. 56
Transactions with owners of the Company Issuance of ordinary (1) shares$’000 5,329––––––5,329–5,329 PDF p. 56
Share issue expenses$’000 (16)––––––(16)–(16) PDF p. 56
Dividends$’000 ––––––(2,662)(2,662)–(2,662) PDF p. 56
Share-based compensation (2) expense$’000 –––––71–71–71 PDF p. 56
Total transactions with owners of the Company$’000 5,313––––71(2,662)2,722–2,722 PDF p. 56
Definitions & sources

Consolidated statement of changes in equity — FY2020 — physical57 — FY2021 report

3 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of changes in equity — FY2020 — physical57 — FY2021 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2020Group — Share capital2020Group — Treasury share reserve2020Group — Foreign currency translation reserve2020Group — Merger reserve2020Group — Capital reserve2020Group — Share compensation/option reserve2020Group — Retained earnings2020Group — Equity attributable to owners of the Company2020Group — Non-controlling interests2020Group — Total equity Source
Group
Transactions with non-controlling interests Subscription of shares in subsidiaries by non-controlling (1),(2) interests$’000 ––––––––341341 PDF p. 57
Total transactions with non-controlling interests$’000 ––––––––341341 PDF p. 57
At 31 December 2020$’000 70,054(105)567(3,572)(4,463)718,55771,10958071,689 PDF p. 57
Definitions & sources

Company statement of changes in equity — FY2021 — FY2021 report

7 metrics

Units appear below each metric. Scroll to compare years

Company statement of changes in equity — FY2021 — FY2021 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2021Company — Share capital2021Company — Treasury share reserve2021Company — Share compensation/option reserve2021Company — Retained earnings2021Company — Total equity Source
2021
At 1 January 2021$’000 70,054(105)715,03375,053 PDF p. 58
Profit for the year, representing total comprehensive income for the year$’000 –––5,9715,971 PDF p. 58
Transactions with owners of the Company Issuance of ordinary shares$’000 14–––14 PDF p. 58
Dividends$’000 –––(8,530)(8,530) PDF p. 58
Share-based compensation expense$’000 ––68–68 PDF p. 58
Total transactions with owners of the Company$’000 14–68(8,530)(8,448) PDF p. 58
At 31 December 2021$’000 70,068(105)1392,47472,576 PDF p. 58
Definitions & sources

Company statement of changes in equity — FY2020 — FY2021 report

8 metrics

Units appear below each metric. Scroll to compare years

Company statement of changes in equity — FY2020 — FY2021 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2020Company — Share capital2020Company — Treasury share reserve2020Company — Share compensation/option reserve2020Company — Retained earnings2020Company — Total equity Source
2020
At 1 January 2020$’000 64,741(105)–3,35967,995 PDF p. 58
Profit for the year, representing total comprehensive income for the year$’000 –––4,3364,336 PDF p. 58
Transactions with owners of the Company Issuance of ordinary shares$’000 5,329–––5,329 PDF p. 58
Share issue expenses$’000 (16)–––(16) PDF p. 58
Dividends$’000 –––(2,662)(2,662) PDF p. 58
Share-based compensation expense$’000 ––71–71 PDF p. 58
Total transactions with owners of the Company$’000 5,313–71(2,662)2,722 PDF p. 58
At 31 December 2020$’000 70,054(105)715,03375,053 PDF p. 58
Definitions & sources

Consolidated statement of cash flows — physical59 — FY2021 report

40 metrics

Units appear below each metric. Scroll to compare years

Consolidated statement of cash flows — physical59 — FY2021 report from ISEC HEALTHCARE LTD. Annual Report 2025
Metric / unit 2021Group2020Group Source
Cash flows from operating activities
Profit before income tax$’000 9,0866,506 PDF p. 59
Adjustments for:
Allowance for/(write-back of) expected credit losses, net$’000 4(12) PDF p. 59
Amortisation of intangible assets$’000 585597 PDF p. 59
Depreciation of property, plant and equipment and right-of-use assets$’000 2,6652,655 PDF p. 59
Interest income$’000 (220)(306) PDF p. 59
Interest expense$’000 400424 PDF p. 59
Impairment of goodwill$’000 –1,484 PDF p. 59
Gain on disposal of property, plant and equipment$’000 –(16) PDF p. 59
Other income from rental rebates$’000 (74)(132) PDF p. 59
Property, plant and equipment written-off$’000 3– PDF p. 59
Share of results of associate$’000 1218 PDF p. 59
Share-based compensation expense$’000 6871 PDF p. 59
Operating cash flows before working capital changes$’000 12,52911,289 PDF p. 59
Working capital changes: Inventories$’000 23(11) PDF p. 59
Trade and other receivables$’000 (567)92 PDF p. 59
Prepayments$’000 (31)(2) PDF p. 59
Trade and other payables$’000 2,554(1,218) PDF p. 59
Cash generated from operations$’000 14,50810,150 PDF p. 59
Income tax paid$’000 (2,208)(2,276) PDF p. 59
Net cash generated from operating activities$’000 12,3007,874 PDF p. 59
Cash flows from investing activities
Proceeds from disposal of property, plant and equipment$’000 –1 PDF p. 59
Purchase of property, plant and equipment$’000 (526)(2,314) PDF p. 59
Purchase of intangible assets$’000 (58)(105) PDF p. 59
Deposits for intended acquisition of property, plant and equipment$’000 (207)– PDF p. 59
Interest received$’000 217298 PDF p. 59
Acquisition of a subsidiary, net of cash acquired$’000 (1,765)(2,946) PDF p. 59
Net cash used in investing activities$’000 (2,339)(5,066) PDF p. 59
Cash flows from financing activities
Dividends paid$’000 (8,530)(2,662) PDF p. 59
Subscription of shares in subsidiaries by non-controlling interests$’000 –341 PDF p. 59
Share issue expenses$’000 –(16) PDF p. 59
Proceeds from exercise of share options$’000 14– PDF p. 59
Principal elements of lease payments, net$’000 (1,582)(1,412) PDF p. 59
Interest paid – lease liabilities$’000 (254)(279) PDF p. 59
Repayment of loan$’000 (843)(284) PDF p. 59
Interest paid – loan$’000 (101)(33) PDF p. 59
Net cash used in financing activities$’000 (11,296)(4,345) PDF p. 59
Net decrease in cash and cash equivalents$’000 (1,335)(1,537) PDF p. 59
Cash and cash equivalents at beginning of year$’000 24,12425,657 PDF p. 59
Effect of exchange rate changes on cash and cash equivalents$’000 (295)4 PDF p. 59
Cash and cash equivalents at end of year$’000 22,49424,124 PDF p. 59
Definitions & sources

Where the money comes from

Segment information

By business

Business segments information - Group 15 lines
Business segments information - Group — Group
Item / unit 2025FY20252024FY2024 Source
Segment revenue
Specialised health services$'000 75,34370,601 PDF p. 117
General health services$'000 3,8683,596 PDF p. 117
Total segment revenue$'000 79,21174,197 PDF p. 117
Segment profit/(loss) after tax
Specialised health services$'000 12,83113,848 PDF p. 117
General health services$'000 586(954) PDF p. 117
Total segment profit/(loss) after tax$'000 13,41712,894 PDF p. 117
Impairment loss for goodwill
Specialised health services$'000 –– PDF p. 117
General health services$'000 –1,520 PDF p. 117
Total impairment loss for goodwill$'000 –1,520 PDF p. 117
Depreciation of property, plant and equipment and right-of-use assets
Specialised health services$'000 4,5873,643 PDF p. 117
General health services$'000 267275 PDF p. 117
Total depreciation$'000 4,8543,918 PDF p. 117
Additions to property, plant and equipment
Specialised health services$'000 18,26113,266 PDF p. 117
General health services$'000 328 PDF p. 117
Total additions to property, plant and equipment$'000 18,26413,294 PDF p. 117
Notes

Information reported to the chief operating decision maker does not include an analysis of assets and liabilities. Segment performance is evaluated based on operating profit or loss. Total rows have no printed label.

By geography

Geographical information - Group 18 lines
Geographical information - Group — Group
Item / unit 2025FY20252024FY2024 Source
Segment revenue
Singapore$'000 12,85311,852 PDF p. 118
Malaysia$'000 63,22759,597 PDF p. 118
Myanmar$'000 3,1312,748 PDF p. 118
Total segment revenue$'000 79,21174,197 PDF p. 118
Segment profit after tax
Singapore$'000 1,189773 PDF p. 118
Malaysia$'000 11,69311,619 PDF p. 118
Myanmar$'000 535502 PDF p. 118
Total segment profit after tax$'000 13,41712,894 PDF p. 118
Impairment loss for goodwill
Singapore$'000 –1,520 PDF p. 118
Malaysia$'000 –– PDF p. 118
Myanmar$'000 –– PDF p. 118
Depreciation of property, plant and equipment and right-of-use assets
Singapore$'000 499410 PDF p. 118
Malaysia$'000 4,1243,281 PDF p. 118
Myanmar$'000 231227 PDF p. 118
Additions to property, plant and equipment
Singapore$'000 3133 PDF p. 118
Malaysia$'000 17,94913,103 PDF p. 118
Myanmar$'000 284158 PDF p. 118
Total additions to property, plant and equipment$'000 18,26413,294 PDF p. 118
Notes

Revenue and operating result are based on the country in which the services are provided and country where the customers are located.

Major customers: no single customer accounted for 5% or more of Group revenue except 1 (FY2024: 1) corporate customer, contributing 9% (FY2024: 9%) of total revenue.

Debt

Borrowings

Borrowing notes 2 tables

Borrowings

Borrowings — Group
Item / unit 2025$'0002024$'000 Source
Borrowings
Bank loan A$'000 –529 PDF p. 105
Bank loan B$'000 406464 PDF p. 105
Bank loan C$'000 396446 PDF p. 105
Bank loan D$'000 15,183– PDF p. 105
Bank loan E$'000 777– PDF p. 105
Current$'000 260672 PDF p. 105
Non-current$'000 16,502767 PDF p. 105
Notes

Loans are floating rate, denominated in Malaysian Ringgit (p.123). Bank loan A (4.17%; 2024: 4.16%) fully settled 1 Aug 2025, secured by freehold land and building. Loan B 4.15% (2024: 4.15%), secured by land and building. Loan C 4.15% (2024: 4.15%), secured by buildings. Loan D 3.76%, secured by strata-title units. Loan E 4.40%. Total 16,762 (2024: 1,439).

Note 5(b) Lease liabilities carrying amounts - current and non-current

Note 5(b) Lease liabilities carrying amounts - current and non-current
Item / unit 2025Group, $'0002024Group, $'0002025Company, $'0002024Company, $'000 Source
Lease liabilities
At 31 December$'000 10,29511,6536197 PDF p. 88
Current$'000 2,1372,2083836 PDF p. 88
Non-current$'000 8,1589,4452361 PDF p. 88

Payout

Dividends & distributions

Dividend policy

ItemValuePeriod / scopeSource
DIVIDEND POLICY The Board does not have a fixed dividend policy. The form, frequency and amount of dividends declared each year will take into consideration the Group’s actual and projected financial performance, results of business operations, level of cash and retained earnings, projected capital expenditure and other investment plans, the terms of borrowing arrangements (if any), plans for expansions and other factors which the Directors may deem appropriate. Group PDF p. 44

Dividends declared and proposed

ItemValuePeriod / scopeSource
Final tax-exempt dividends on ordinary shares for 2025 0.58 cents per share FY2025 proposed final tax-exempt (one-tier) dividend, subject to shareholders' approval at AGM; not recognised as liability at 31 December 2025 PDF p. 114
Final tax-exempt dividends on ordinary shares for 2024 0.70 cents per share FY2024 final tax-exempt dividend (comparative), paid in 2025 PDF p. 114
First interim tax-exempt dividend for 2025 nil FY2025 first interim tax-exempt dividend PDF p. 114
First interim tax-exempt dividend for 2024 0.30 cents per share FY2024 first interim tax-exempt dividend (comparative) PDF p. 114

Extracted from ISEC HEALTHCARE LTD. Annual Report 2025 and checked against the cited pages; see the original report for full context.

Auditor’s report

Audit & risk signals

Audit opinion

ItemValuePeriod / scopeSource
Audit firm FORVIS MAZARS LLP Group PDF p. 55
Engagement partner Zhang Liang Group PDF p. 55
Opinion properly drawn up in accordance with the provisions of the Companies Act 1967 (the “Act”) and Singapore Financial Reporting Standards (International) (“SFRS(I)s”) so as to give a true and fair view Group and Company PDF p. 51

Extracted from ISEC HEALTHCARE LTD. Annual Report 2025 and checked against the cited pages; see the original report for full context.

How to read these figures

Group and parent company or bank figures are labelled separately. Parentheses indicate negative amounts; a dash and NA retain the report’s notation.

Comparative figures follow ISEC HEALTHCARE LTD. Annual Report 2025, including retrospective adjustments. Adjusted and reported earnings may have different definitions; refer to each statement’s notes.

The audited statements print Group profit or loss/comprehensive income and cash flows, Group/Company balance sheets and Group/Company changes in equity. Separate Company profit or loss/comprehensive income and cash-flow statements are not printed.

The original FY2023 Company equity table contains112 in retained earnings for the treasury-share transfer, whereas the FY2024 comparative prints a dash. Both reported versions and sources are preserved.

These tables show the available extracted figures. The original annual report contains the full statements, notes and definitions.